Enspryng (satralizumab)

pCPA File Number: 21451
Negotiation Status:
Concluded with an LOI
Indication(s):
neuromyelitis optica spectrum disorders (NMOSD)
Sponsor/Manufacturer:
Hoffmann-La Roche Limited
CADTH Project Number:
SR0663
pCPA Engagement Letter Issued:
Negotiation Process Concluded: